Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B

We examined the association between serum miRNA (-192-5p, -122-3p, -320a and -6126-5p) levels and the efficacy of pegylated interferon (Peg-IFN) monotherapy for chronic hepatitis B (CHB) patients. We enrolled 61 CHB patients treated with Peg-IFNα-2a weekly for 48 weeks, of whom 12 had a virological...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagura, Yoshihito, Matsuura, Kentaro, Iio, Etsuko, Fujita, Koji, Inoue, Takako, Matsumoto, Akihiro, Tanaka, Eiji, Nishiguchi, Shuhei, Kang, Jong-Hon, Matsui, Takeshi, Enomoto, Masaru, Ikeda, Hiroki, Watanabe, Tsunamasa, Okuse, Chiaki, Tsuge, Masataka, Atsukawa, Masanori, Tateyama, Masakuni, Kataoka, Hiromi, Tanaka, Yasuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843190/
https://www.ncbi.nlm.nih.gov/pubmed/35157730
http://dx.doi.org/10.1371/journal.pone.0263844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843190/
https://www.ncbi.nlm.nih.gov/pubmed/35157730
http://dx.doi.org/10.1371/journal.pone.0263844

Ejemplares similares